Background: Expression of the vitamin D receptor (VDR) is regulated by hormones in a tissue-specific manner. Results: Enhancers potentially involved in the regulation of VDR expression were characterized in mouse tissues in vivo. Conclusion: Regulation of VDR expression is mediated by tissue-specific enhancers. Significance: Defining potential regulatory regions allows us to predict VDR expression in target tissues.The biological actions of 1,25-dihydroxyvitamin D 3 (1,25 (OH) 2 D 3 ) are mediated by the vitamin D receptor (VDR), whose expression in bone cells is regulated positively by 1,25(OH) 2 D 3 , retinoic acid, and parathyroid hormone through both intergenic and intronic enhancers. In this report, we used ChIP-sequencing analysis to confirm the presence of these Vdr gene enhancers in mesenchyme-derived bone cells and to describe the epigenetic histone landscape that spans the Vdr locus. Using bacterial artificial chromosome-minigene stable cell lines, CRISPR/Cas9 enhancer-deleted daughter cell lines, transient transfection/ mutagenesis analyses, and transgenic mice, we confirmed the functionality of these bone cell enhancers in vivo as well as in vitro. We also identified VDR-binding sites across the Vdr gene locus in kidney and intestine using ChIP-sequencing analysis, revealing that only one of the bone cell-type enhancers bound VDR in kidney tissue, and none were occupied by the VDR in the intestine, consistent with weak or absent regulation by the 1,25(OH) 2 D 3 hormone in these tissues, respectively. However, a number of additional sites of VDR binding unique to either kidney or intestine were present further upstream of the Vdr gene, suggesting the potential for alternative regulatory loci. Importantly, virtually all of these regions retained histone signatures consistent with those of enhancers and exhibited unique DNase I hypersensitivity profiles that reflected the potential for chromatin access. These studies define mechanisms associated with hormonal regulation of the Vdr and hint at the differential nature of VDR binding activity at the Vdr gene in different primary target tissues in vivo.
The vitamin D receptor (VDR)2 is a member of the nuclear receptor family of genes that mediates the biological activities of 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ) in target cells (1)(2)(3)(4). Based upon detection of the VDR protein by immunological methods, the VDR gene is expressed in a wide variety of cell and tissue types both in vitro and in vivo. These tissue types include the intestine, kidney, skeleton, and parathyroid glands, which all play a role in calcium and phosphorus homeostasis (2,5,6) and additional tissues/cells whose functions are not directly involved in the regulation of mineral metabolism. At these particular sites of VDR expression, which include the skin (7,8), immune cells (9 -11), pancreatic  cells (12-14), reproductive tissues (15)(16)(17), placenta (18,19), and others, numerous roles for the VDR have been identified, all associated with the ability of the VDR to regulate th...